Sir, neural implants powered by artificial intelligence (AI) have the potential to revolutionise communication and improve quality of life for individuals, particularly those suffering from Alzheimer's disease. Recent research indicates that AI-powered Brain Machine Interfaces (BMIs) can effectively identify and track the progression of Alzheimer's, leading to earlier diagnosis and intervention.1 This early identification may slow the disease's progression, improving patient outcomes.

Moreover, AI-driven neural implants offer the ability to detect and monitor changes in brain activity, allowing medical professionals to tailor treatment plans and medication regimens to individual patients' needs. This personalised approach to therapy has the potential to optimise medical resources and improve patient outcomes.2 For individuals with Alzheimer's disease, BMIs offer a unique opportunity to enhance communication and overall quality of life. Studies have shown that BMIs can detect and identify denture trackers in edentulous Alzheimer's patients, enabling clearer expression of their needs.3,4 Additionally, AI-powered brain implants could potentially allow patients to convey their thoughts and emotions without the need for language, further improving their quality of life.

The history of BMIs can be traced back to Hans Berger's invention of the electroencephalogram in 1924. However, it was not until the 1970s that the term 'Brain Machine Interface' first appeared in scientific literature. Since then, the field has progressed significantly, with companies such as Neuralink, founded by Elon Musk,5,6 working towards the goal of enhancing human cognitive and sensory capabilities.

In conclusion, AI-powered neural implants have the potential to transform the field of medicine, particularly in the realm of Alzheimer's disease treatment. By enabling early diagnosis and tailored treatment plans, these devices have the potential to improve patient outcomes and overall quality of life.